Cost-effectiveness controversy.
Cox
T M
TM
D003362:Cost-Benefit Analysis; D005776:Gaucher Disease / Q000188:drug therapy / Q000191:economics*; D005962:Glucosylceramidase / Q000191:economics* / Q000627:therapeutic use; D006801:Humans